Debt-to-equity of GOLDENWELL BIOTECH, INC. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GOLDENWELL BIOTECH, INC. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • GOLDENWELL BIOTECH, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -386%, a 191% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GOLDENWELL BIOTECH, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -386% -810% -191% 30 Sep 2025
Q2 2025 -551% -779% -341% 30 Jun 2025
Q1 2025 -889% -998% -911% 31 Mar 2025
Q4 2024 2746% +2680% +4078% 31 Dec 2024
Q3 2024 424% +386% +1030% 30 Sep 2024
Q2 2024 229% +205% +857% 30 Jun 2024
Q1 2024 110% +91% +480% 31 Mar 2024
Q4 2023 66% +50% +318% 31 Dec 2023
Q3 2023 38% +13% +50% 30 Sep 2023
Q2 2023 24% -10% -29% 30 Jun 2023
Q1 2023 19% -22% -54% 31 Mar 2023
Q4 2022 16% -24% -60% 31 Dec 2022
Q3 2022 25% -4% -14% 30 Sep 2022
Q2 2022 34% +16% +86% 30 Jun 2022
Q1 2022 41% 31 Mar 2022
Q4 2021 40% 31 Dec 2021
Q3 2021 29% 30 Sep 2021
Q2 2021 18% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.